Aethlon Medical Inc.
3030 Bunker Hill Street
Suite 4000
San Diego,
CA 92109
Phone: 858-459-7800
Web Site: http://www.aethlonmedical.com
| REUTERS ABRIDGED BUSINESS SUMMARY | |
| Aethlon Medical, Inc., a development stage medical device company, focuses on research and development of diagnostic and therapeutic filtration devices to improve the health of individuals afflicted with infectious diseases and cancer. The companys lead product, the Hemopurifier, is a platform technology that combines the scientific methods of hemodialysis and affinity chromatography as a means to augment the natural immune response of clearing infectious viruses from the blood before the occurrence of cell and organ infection. The Hemopurifier targets to inhibit disease progression of hepatitis-c virus and human immunodeficiency virus, as well as bioterror and pandemic threats. The company was founded in 1991 and is based in San Diego, California. |
|
| Key Statistics | More from Reuters
Expanded Business Description |
| |
| REUTERS ABRIDGED FINANCIAL SUMMARY | |
| | Pay | Exercised | Mr. James A. Joyce PhD., 48
Founder, Chairman, Chief Exec. Officer, Pres, Chief Financial Officer, Principal Accounting Officer and Sec. |
N/A
| N/A | Dr. Richard H. Tullis Ph.D., 64
Chief Scientific Officer, VP of Bus. Devel., Director and Member of Scientific Advisory Board |
N/A
| N/A | Dr. Harold H. Handley Jr., Ph.D., 60
Pres |
N/A
| N/A | Mr. Sunil Sawhney ,
Head of Clinical Studies |
N/A
| N/A | Mr. Jim Frakes , 53
Sr. VP of Fin. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
Help
Profile
Reuters offers more in-depth
